Document is current
Any future updates will be listed below
-
Authors
de Nijs, Jessica
Burger, Thijs J.
Janssen, Ronald J. https://orcid.org/0000-0001-9622-5420
Kia, Seyed Mostafa https://orcid.org/0000-0002-7128-814X
van Opstal, Daniël P. J. https://orcid.org/0000-0002-6038-7177
de Koning, Mariken B.
de Haan, Lieuwe
,
Alizadeh, Behrooz Z. https://orcid.org/0000-0002-1415-8007
Bartels-Velthuis, Agna A.
van Beveren, Nico J.
Bruggeman, Richard
de Haan, Lieuwe
Delespaul, Philippe https://orcid.org/0000-0001-7420-0898
Luykx, Jurjen J. https://orcid.org/0000-0002-6439-2774
Myin-Germeys, Inez https://orcid.org/0000-0002-3731-4930
Kahn, Rene S. https://orcid.org/0000-0001-5909-8004
Schirmbeck, Frederike
Simons, Claudia J. P. https://orcid.org/0000-0002-7637-3589
van Amelsvoort, Therese
van Os, Jim
van Winkel, Ruud
Cahn, Wiepke https://orcid.org/0000-0002-0482-8759
Schnack, Hugo G. https://orcid.org/0000-0002-4620-3853
- License Information
-
More Information
Article History
Received: 29 June 2020
Accepted: 17 February 2021
First Online: 2 July 2021
Competing interests
: L.H. has received research funding form Eli Lilly and honoraria for educational programs from Eli Lilly, Jansen Cilag, BMS, Astra Zeneca. R.K. is or has been a member of DSMB for Janssen, Otsuka, Sunovion. and Roche. W.C. is or has been an unrestricted research grant holder with, or has received financial compensation as an independent symposium speaker or as an consultant from, Eli Lilly, BMS, Lundbeck, Sanofi-Aventis, Janssen-Cilag, AstraZeneca and Schering-Plough. I.M.-G. is an unrestricted research grant holder with Janssen-Cilag and has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Lundbeck, and Janssen-Cilag. All other authors report no potential competing interests.
